News
1h
Zacks Investment Research on MSNBuy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations?Pfizer PFE shares spiked +3% in Tuesday’s trading session as the pharmaceutical giant was able to crush its Q1 earnings expectations this morning. Still, Pfizer stock has fallen 10% year to date and ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Novo Nordisk partners with telehealth ...
After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.
Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...
StockStory.org on MSN6h
Why Is WeightWatchers (WW) Stock Soaring TodayWhat Happened? Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 132% in the afternoon session after the ...
Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...
The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster cancer treatment, the company said.
Novo Nordisk launched access to its popular weight loss GLP-1 drug, Wegovy, through multiple telehealth platforms, including Hims & Hers.
A new report shows up to 7.2 million Americans aged 65 and older are living with Alzheimer’s disease, an increase of about 300,000 cases.
“The Drugs & Cosmetics (Compounding of Offences) Rules 2025 have been notified so as to avoid legal proceedings in the court ...
Deals with Hims & Hers, LifeMD and Ro following a court's dismissal of a lawsuit challenging the FDA's determination Wegovy ...
The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results